Position in LH
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,213,800
-$36,471 QoQ
Shares Held
4,335
-7.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#426
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $6,017,727 across 6 Diagnostics & Research names. LH ranks #3 (20.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
11,279 | $2,148,423 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,690 | $1,348,658 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
4,335 | $1,213,800 | |
| 4 | ILMN |
Illumina, Inc.
|
3,970 | $698,045 | |
| 5 | NTRA |
Natera, Inc.
|
1,500 | $407,175 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
383 | $201,626 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,213,800 | 4,335 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,250,271 | 4,686 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,198,453 | 4,777 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,388,222 | 4,836 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,270,023 | 4,838 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $1,243,995 | 5,345 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,310,105 | 5,713 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,343,561 | 6,012 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,458,963 | 7,169 | Shares | Sole | 2024-07-10 | |
| No filing history on record for this holder in this stock. | ||||||